Comments
Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 11.26 crore for the first quarter ended June 30, 2011.
The company had posted a net profit of Rs 48 lakh in the same period previous fiscal, SPARC said in a statement.
The company’s total income stood at Rs 10.08 crore in the June quarter, while the same was Rs 14.73 crore in the corresponding period of last financial year.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Shares of SPARC were trading at Rs 81.95 on the Bombay Stock Exchange in late afternoon trade, down 3.64 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.